drugset / Trial / NCT01331746

Proof-of-concept (PoC) Study of APD515

NCT01331746 ↗

Phase 2 Completed 32 enrolled Acacia Pharma Ltd
RandomizedCrossoverDouble-blindTreatment

Summary

A study to look at the effectiveness of a drug called APD515, designed to be applied to the lining inside the mouth, at relieving dryness of the mouth. Study will compare one week of treatment with APD515 to one week of treatment with matching placebo to see which has better effect on patient's mouth dryness, according to their own score.

Timeline

Start
2011-09
Primary completion
2012-12
Completion
2012-12

Drugs

EvaluationDrugModalityDoseRoute
Subject APD515 Unknown 20 mg Other

Indications

No indication recorded.